Marc Daukandt

CBO at Xpress Biologics

Liège, Walloon Region, Belgium

About

Co-founder of Xpress Biologics, a new Contract Service Organisation dedicated to the production of biomolecules for pre-clinical proofs of concept Expertise in molecular biology and the development of microbial expression systems (yeast and bacteria) for the production of recombinant proteins and plasmid DNA for Biotech & Pharma companies. Laboratory, people and financial management skills.

Experience

  • Xpress Biologics (12 yrs 9 mos)
    • CBO
      Sep 2021 - Present · 4 yrs 10 mos

    • CEO
      Apr 2014 - Sep 2021 · 7 yrs 6 mos

    • Business Development Manager
      Oct 2013 - Sep 2021 · 8 yrs

      Organization of the Sales & Marketing activities. Identification of collaborations & partnerships. Prospection.

  • Eurogentec (Liège, Walloon Region, Belgium)
    • New Technologies Development Manager
      Sep 2008 - Sep 2013 · 5 yrs 1 mo

      Evaluation and optimization of new or existing technologies for the production of biologics (proteins and plasmid DNA). Development of a large scale "GMP" pDNA production process. Development of antibody fragment production in P. pastoris.

    • DNA array production manager
      Oct 2003 - Aug 2008 · 4 yrs 11 mos

      Organization of the DNA array production, hybridization and analysis activities. Design and development of new DNA array microchips.

  • Scientist at Dyax
    Oct 2001 - Sep 2003 · 2 yrs

    Set-up and supervision of a high-throughput sequencing platform.

  • Sequencing laboratory supervisor at Eurogentec
    Apr 2000 - Sep 2001 · 1 yr 6 mos

    Supervision of the sequencing activity.

  • Université de Liège (ULg) (5 yrs 7 mos)
    • Research Scientist
      Apr 1997 - Mar 2000 · 3 yrs

      Identification of androgen-independent prostate cancer markers.

    • Research Scientist
      Sep 1994 - Mar 1997 · 2 yrs 7 mos

      Identification of angiogenesis inhibitor for the treatment of cancer.